SERGIO CALIXTO-MONTANEZ: Open Payments
NPI 1316268162 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,364 in 63 payments from 15 companies in 2025. Trend: 2023 $1,222 · 2024 $2,108 · 2025 $1,364
Food & beverage: $1,364
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $236 |
| Lilly USA, LLC | 12 | $214 |
| PFIZER INC. | 11 | $200 |
| Novo Nordisk Inc | 5 | $191 |
| AstraZeneca Pharmaceuticals LP | 9 | $161 |
| Abbott Laboratories | 3 | $65 |
| Amgen Inc. | 4 | $63 |
| Verona Pharma, Inc. | 2 | $51 |
| Exact Sciences Corporation | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
Products named: PREVNAR 20, JARDIANCE, Wegovy, MOUNJARO, CREON, FREESTYLE LIBRE 3, AIRSUPRA, FARXIGA.
Industry payments across TX — which companies pay providers there.
